| Literature DB >> 27523588 |
Xianyi Yang1, Danyang Chen1, Lin Chai1, Hui Duan1, Hui Guo2, Shuang Li1, Min Xiao1, Hongxia Chen3.
Abstract
BACKGROUND Previous reports suggest that homoplantaginin, one of the compounds isolated from Salvia plebeia, has a protective and therapeutic effect on hepatocyte injury. We present a case of serious liver and kidney damage due to incorrect use of Salvia plebeia in a patient with a history of thyroid tumorectomy, who was successfully treated for poisoning with blood purification and systemic, comprehensive critical care. CASE REPORT A 54-year-old female patient with salvia intoxication combined with multiple organ dysfunction was transported to our emergency center by ambulance after presenting with nausea, vomiting, and skin yellowing. On arrival, she exhibited fatigue, dizziness, lightheadedness, yellowish discoloration of her skin, breathing difficulties, and low back pain, all of which was suggestive of salvia intoxication combined with multiple organ dysfunction. The treatment strategy was to immediately speed up the excretion of toxins and administered blood purification therapy. She also displayed disseminated intravascular coagulation (DIC), which was successfully treated with plasma infusion of blood coagulation factor combined with LMWH acupuncture therapy. CONCLUSIONS Salvia plebeia should only be considered for use in patients who have infectious disease or oxidative stress related disease and only at an appropriate dose. In addition, for patients with salvia poisoning, prompt administration of blood purification therapy and systemic comprehensive measures involving multiple supportive therapies can save such patients.Entities:
Mesh:
Year: 2016 PMID: 27523588 PMCID: PMC4987065 DOI: 10.12659/ajcr.897445
Source DB: PubMed Journal: Am J Case Rep ISSN: 1941-5923
Laboratory data findings on admission.
| White cell count (per mm3) | 3.5–9.5 | 14.00 | 6.05 | 14.12 | 5.79 | 6.05 | 10.37 | 14.12 | 5.79 | |
| Platelet counts (109/L) | 125–350 | 113.00 | 10 | 34 | 48 | 6 | 13 | 34 | 48 | |
| Red cell count (1012/L) | 3.8–5.1 | 4.12 | 3.38 | 2.46 | 2.57 | 3.38 | 2.66 | 2.46 | 2.57 | |
| Hemoglobin (g/L) | 115–150 | 120.00 | 106 | 74 | 80 | 106 | 80 | 74 | 80 | |
| Hematocrit | 0.35–0.45 | 0.32 | 0.3 | 0.22 | 0.24 | 0.3 | 0.24 | 0.22 | 0.24 | |
| Alanine aminotransferase (IU/L) | 0–40 | 1567.00 | 1858 | 383 | 66 | 881 | 532 | 383 | 110 | 66 |
| Aspartate transaminase (IU/L) | 0–35 | 1531.00 | 1802 | 222 | 24 | 689 | 375 | 222 | 24 | 24 |
| Total bilirubin (μmol/L) | 2–20.4 | 41.20 | 60.9 | 51.2 | 41 | 54.2 | 59.2 | 51.2 | 24.5 | 41 |
| Unconjugated bilirubin (μmol/L) | 1–13.7 | 18.40 | 17.1 | 19.9 | 24 | 14.1 | 21.9 | 19.9 | 11.2 | 24 |
| Conjugated bilirubin (μmol/L) | 0–6.8 | 22.80 | 43.8 | 27.8 | 17 | 40.1 | 37.3 | 27.8 | 13.3 | 17 |
| Total protein (g/L) | 65–85 | 60.00 | 58.3 | 51.2 | 68.2 | 44 | 48 | 51.2 | 47.1 | 68.2 |
| Albumin (g/L) | 40–55 | 29.00 | 36.4 | 34.9 | 43.5 | 26 | 33.1 | 34.9 | 30.8 | 43.5 |
| Globulin (g/L) | 20–40 | 31.00 | 21.9 | 16.3 | 24.7 | 18 | 14.9 | 16.3 | 16.3 | 24.7 |
| Glucose (mmol/L) | 3.9–6.1 | 6.42 | 7.48 | 6.79 | 5.08 | 9.82 | 6.72 | 6.79 | 5.46 | 5.08 |
| Blood urea nitrogen (mmol/L) | 1.7–8.3 | 25.33 | 29.29 | 13.49 | 3.32 | 13.93 | 8.39 | 13.49 | 8.2 | 3.32 |
| Serum creatinine (μmol/L) | 44–120 | 314.00 | 348.7 | 131.7 | 69.1 | 151.8 | 113.1 | 131.7 | 80 | 69.1 |
| Cystatin-C (mg/L) | 0–1.03 | 2.77 | 0.95 | 0.82 | 1.14 | 1.37 | 0.82 | 0.67 | ||
| Creatinine kinase (IU/L) | 25–170 | 2470 | ||||||||
| Creatinine kinase-MB (IU/L) | 0–17 | 59 | ||||||||
| Lactate dehydrogenase (IU/L) | 100–240 | 1153 | ||||||||
| Prothrombin time (s) | 9––13 | 19.3 | 12.9 | 14 | 13.2 | 13.4 | 14 | 13.2 | ||
| Activated partial thrombin time (s) | 25–35 | 40.9 | 69.9 | 50.2 | 74.1 | 66.1 | 50.2 | 34.8 | ||
| International normalized ratio | 0.8–1.5 | 1.77 | 1.18 | 1.28 | 1.21 | 1.23 | 1.28 | 1.21 | ||
| D-mier (μg/mL) | 0–0.25 | 1.68 | 0.91 | 1.08 | ||||||
| Fibrinogen degradation product (μg/mL) | 0–2.01 | 3.46 | 6.56 | 6.28 | ||||||
| C-reactive protein (g/L) | 0–5 | 129.21 | 55.16 | |||||||